GHA CERTIFIED FOR LONGEVITY MEDICINE™

Evidence-Based Services, Products & Platforms for Healthy Longevity

For companies that supply longevity medicine — not for clinics delivering care.

Independent certification for organizations supporting the longevity ecosystem with evidence, responsible claims, safety, transparency, and enterprise-ready systems.

Explore certification →request program information →

What Is GHA Certified for Longevity Medicine™?

GHA Certified for Longevity Medicine™ is an independent certification for companies whose products, platforms, or services support longevity medicine — including diagnostics, medical devices, digital health and AI platforms, monitoring tools, and nutraceuticals. It evaluates evidence, claims integrity, safety systems, and enterprise capability within a defined scope. It is not an endorsement of any product.

The Longevity Ecosystem Extends Beyond the Clinic

Healthy longevity increasingly depends on an ecosystem of diagnostics, medical devices, digital platforms, artificial intelligence, therapeutic technologies, supplements, monitoring tools, and other services and products that influence how patients are assessed, supported, treated, and followed over time.

But inclusion in a longevity program does not, by itself, establish that a product is evidence-based, that its claims are appropriate, or that the company behind it is prepared to support responsible clinical use.

GHA Certified for Longevity Medicine™ provides an independent certification framework for organizations whose defined products, services, or platforms support healthy longevity medicine.

A longevity claim should never be stronger than the evidence supporting it.

Evidence Before Marketing

The certification is designed to examine whether the organization has appropriate systems to establish, document, maintain, and responsibly communicate the evidence supporting its defined scope.

This includes intended use, regulatory status, evidence generation and management, scientific independence, claims substantiation, appropriate clinical-use guidance, contraindications and warnings where applicable, post-market monitoring, complaint and adverse-event processes, data governance, and the relationship between scientific and commercial functions.
Certification is not a shortcut to scientific legitimacy. It is a framework for demonstrating that evidence, claims, safety, and commercial practices remain aligned.

What GHA Evaluates

01

Organizational Governance & Quality Management

Accountable leadership and a functioning quality management system.

02

Defined Scope, Intended Use & Strategic Alignment

An explicit statement of what the product does, who it is for, and what it is not intended to do.

03

Regulatory Affairs & Post-Market Compliance

Accurate regulatory classification in each market, and compliance obligations after launch.

04

Design, Development, Manufacturing and/or Service Controls, as Applicable

Documented controls proportionate to the product or service type.

05

Clinical & Scientific Governance

Qualified scientific oversight, structurally independent of commercial pressure.

06

Evidence Generation, Evaluation & Management

How evidence is produced, appraised, kept current, and retired when superseded.

07

Claims Governance & Marketing Integrity

A defined process ensuring every public claim traces to substantiating evidence.

08

Customer Training & Clinical-Use Guidance

The instruction and support supplied to clinicians who use the product with patients.

09

Post-Market Surveillance, Complaints & Safety

Systematic collection and investigation of complaints, safety signals, and adverse events.

10

Healthy Longevity and Healthspan Claim Discipline

Specific controls on longevity, healthspan, biological-age, and anti-aging claims.

11

Enterprise Partnership Governance & Contracting

Contracting practice and accountability structures for institutional customers.

12

Enterprise Data, Evidence & Reporting

The data and outcome reporting enterprise partners require.

13

AI, Digital Integration & Cybersecurity Governance, Where Applicable

Model governance, clinical-decision-support safeguards, integration controls, and security.

14

Multi-Site and Cross-Border Support, Where Applicable

Capability to support customers operating across multiple sites and jurisdictions.

Who Is Eligible for GHA Certification?

The certification framework is intended for qualifying organizations providing products, technologies, platforms, or services used within the healthy longevity ecosystem. Depending on the defined scope, this may include diagnostics and biomarker technologies, digital health and AI platforms, medical devices, therapeutic technologies, monitoring tools, nutraceutical and wellness products, clinical support services, and other evidence-based or evidence-governed solutions supporting longevity medicine.

GET Accredited →
dIAGNOSTICS & BIOMARKERSDIGITAL HEALTH & AIMEDICAL SERVICESTHERAPEUTIC TECHNOLOGIESMONITORING TOOLSNUTRACEUTICALSCLINICAL SUPPORT SERVICES

*Certification applies only to the specific scope evaluated by GHA. It should never be interpreted as a blanket endorsement of every product, service, indication, or health claim offered by a company.

From Scientific Credibility to Enterprise Adoption

Products and platforms seeking adoption by sophisticated longevity programs need more than a compelling consumer proposition. Enterprise partners increasingly require regulatory discipline, scalable quality systems, cybersecurity, clinical integration, transparent contracting, evidence and outcomes data, claims governance, multi-site support, and accountable partnership structures.The GHA framework therefore evaluates both the evidence foundation and the systems required to operate responsibly within institutional healthy longevity environments.
Evidence earns credibility. Enterprise readiness makes responsible adoption possible.

Frequently Asked Questions

What types of companies can be certified?

Companies supplying the longevity medicine ecosystem: diagnostics and biomarker technologies, digital health and AI platforms, medical devices, therapeutic technologies, monitoring tools, nutraceutical and wellness products, and clinical support services. The certification is for suppliers to longevity medicine, not for clinics delivering care — those should review GHA Longevity Medicine Accreditation™.

Is certification an endorsement of the product?

No. Certification evaluates whether a company's systems for evidence, claims, safety, and quality are sound within a defined scope. It does not assert that a product works, and it confers no regulatory approval. It applies only to the scope assessed, never to a company's entire catalogue.

What does "defined scope" mean in practice?

Each certification names the specific products, services, or platforms assessed. A company with six products may certify two. Marketing may reference certification only for the scope actually evaluated, and GHA treats scope misrepresentation as a claims-integrity failure.

How does GHA evaluate healthspan and biological-age claims?

Claim discipline is an assessed domain. Standards require that every public claim about longevity, healthspan, biological age, or anti-aging effect trace to substantiating evidence, that the strength of that evidence be characterized honestly, and that limitations be disclosed rather than omitted.

Does certification cover AI and digital health platforms?

Yes, where applicable to the defined scope. Assessment covers model governance, clinical-decision-support safeguards, data governance, integration controls, and cybersecurity — alongside the evidence and claims requirements that apply to every certified organization.

Do supplements and nutraceuticals qualify?

Nutraceutical and wellness products fall within the eligible categories, subject to the same requirements as any other scope: documented intended use, accurate regulatory classification, substantiated claims, post-market surveillance, and disciplined communication about what the evidence does and does not support.

How does certification help with enterprise adoption?

Enterprise partners — health systems, employers, insurers — typically require regulatory discipline, scalable quality systems, cybersecurity, clinical integration support, transparent contracting, and outcomes reporting before adoption. Certification provides independent evidence of those capabilities in a single assessment, rather than each partner running its own diligence.

What is the difference between GHA accreditation and GHA certification?

GHA accredits healthcare organizations that treat patients. GHA certifies laboratories and the companies whose products, platforms, and services support longevity care. Both are independent evaluations against published standards; the distinction is whether the entity delivers care directly.

Begin the Accreditation Conversation

REQUEST PROGRAM INFORMATION